NCT04532281
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
1,630 public trials
214 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT04532268
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT03199066
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Charles University General Hospital Prague, Czechia
NCT02259556
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
- Locations
-
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
Enrolling by Invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +30 more
- Locations
-
- Linear Clinical Research Ltd Nedlands, Australia
- Scientia Clinical Research Randwick, Australia
- Ghent University Hospital Ghent, Belgium
- Hopital Claude Huriez Lille, France
Enrolling by Invitation
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
NCT03226704
- Conditions
- Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma, Hematologic Diseases, +15 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Enrolling by Invitation
Biology Studies of Hematologic Cancers
NCT00923442
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +20 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Enrolling by Invitation
Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study
NCT04996706
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- University of Miami: Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
Enrolling by Invitation
Long-Term Follow-up Study
NCT05332054
- Conditions
- B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of California Irvine Irvine, California, United States
Not Yet Recruiting
A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
NCT07735533
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
- Locations
-
Not specified